| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Director
2 companies
Klinger Shannon Thyme is a Chief Legal Officer at Moderna, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 529 | $44.68 | $23,637.31 | -2.5% | -21.2% | -38.1% | |
| Dec 3, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 112 | $43.30 | $4,849.28 | -0.6% | -28.9% | -40.9% | |
| Nov 29, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 1,418 | $42.79 | $60,674.94 | -6.7% | -27.8% | -39.7% | |
| Sep 9, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 551 | $73.57 | $40,538.78 | -2.9% | -40.4% | -68.1% | |
| Sep 3, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 114 | $76.99 | $8,776.75 | -0.6% | -39.3% | -67.0% | |
| Aug 29, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 162 | $78.03 | $12,640.21 | -0.9% | -44.1% | -69.0% | |
| Aug 28, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 1,319 | $79.39 | $104,721.87 | -7.1% | -46.3% | -68.8% | |
| Jun 10, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 5,178 | $148.09 | $766,784.65 | -24.5% | -48.4% | -81.4% | |
| Jun 3, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 122 | $140.72 | $17,167.82 | -1.1% | -50.7% | -81.2% | |
| May 29, 2024 | MRNA Moderna, Inc. | Chief Legal Officer | Sale+OE | 183 | $144.50 | $26,444.36 | -1.7% | -46.6% | -81.8% |